Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)ide Analogue-treated Participants with HBeAg Negative Chronic Hepatitis B in the Asia Pacific Region'. The following are the other relevant details related to the trial:
Therapeutic Area: Infectious Diseases
Trial Centre(s):
National University Hospital
Trial Status: NA
Principal Investigator(s):
Dr Lim Seng Gee
Published by HT Digital Content Services with permission from Health Daily Digest....